KIMS Q4 FY26 earnings call.
A source-linked concall view: reported numbers, management language, guidance, commitments and risks that should carry forward.
ConCallIQ research layer
Signal, with the source still visible.
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Revenue
₹1,075 Cr
verified against source
Revenue YoY
34.8%
reported change
EBITDA
₹216 Cr
latest reported figure
Source
screener in
record provenance
Actual signal trajectory
Where this quarter sits.
Quarter read
What the record says.
KIMS reported Q4 FY26 revenue of INR 175 cr (34.8% YoY growth) with EBITDA at INR 216 cr and margin compression to 19.9% from 25.3% in Q4 FY25. PAT declined sharply to INR 33 cr vs INR 106 cr year-ago. The margin contraction reflects heavy investment in new units—Karnataka (Mahadev 49 cr, E-City 17 cr), Maharashtra (Tan 47 cr), and Nasik—which collectively incurred ~INR 120 cr EBITDA loss for FY26. Management attributed slower ramp-up primarily to delayed insurance empanelments following GIC's common empanelment initiative. The company plans INR 1,500 cr QIP primarily to retire ~INR 1,000 cr of debt (currently ~INR 3,000 cr) and maintain healthy debt-to-equity ratio near 1:2. Kundapur relocation to 800-bed facility begins June 2026 with minimal capex remaining. Mature units maintained ~29% EBITDA margin. The Telangana cluster is expected to grow 10-12% in FY27 despite new facility commissioning. Risk includes ongoing insurance delays impacting new unit ramp-up and competitive intensity in Hyderabad where 4-5 new hospitals commissioned.
Colored figures show movement against the previous available record.
Guidance to track
- Company plans to retire approximately INR 1,000 cr of debt from the INR 1,500 cr QIP proceeds, bringing debt-to-equity closer to the target 1:2 ratio from current 1:3.
- Mahadev hospital (commissioned October 2025) should achieve EBITDA breakeven before October 2026, while Electronic City should turn EBITDA positive by March 2027.
- Despite new facility commissioning (Kundapur, Pali), the Telangana cluster should deliver 10-12% revenue growth in FY27 as mature business continues expansion.
- Shift to new 800-bed Kundapur facility begins first week of June 2026; 400-500 beds commissioned in Phase 1 with remaining 300 beds to follow as occupancy increases. Capex of INR 50-75 cr remains for FI28-29.
Risks flagged
- GIC's common empanelment initiative created confusion and significantly delayed insurance approvals for new hospitals. Nasik still awaiting Star and Ayushman; Bangalore insurance may take 3-4 more months. This has directly impacted revenue ramp-up for new units.
- Company expects continued EBITDA drag from new units in FY27 despite gradual narrowing of losses. Management declined to quantify expected losses for FY27-28, indicating uncertainty about the trajectory.
- The planned June 2026 transition from old 200-bed facility to new 800-bed facility involves operational disruption. Old facility may run for 2-3 months post-transition, potentially causing temporary margin pressure and patient transition challenges.
- When pressed on common empanelment initiative legality and pricing concerns raised by peers, management declined to comment stating 'I don't think it's appropriate to comment on that now.' This leaves uncertainty around potential pricing pressure if common empanelment becomes mandatory.
Key quotes
- The idea is now that the debt has reached its peak close to 3,000 plus crores the idea is we retire some debt and use the cash flow to do more green field projects which anyways will take three to four years before they get commissioned.
- What we underestimated is the time it takes to now get insurance empanelments vis-a-vis how it was before. That has caused some delay in ramp up but otherwise overall we're very happy with all the four hospitals.
- Had we got empanelments like we could have in the past the ramp up would have significantly been better than what it is today.
- For the matured unit we continue to do about 29 and a half percent margin on the overall base which we continue to do for these mature units.
Research modules
